Insider · CIK 0001814892
Lawrence Eichenfield
Files at VRCA (Verrica Pharmaceuticals Inc.). First filing -, latest -.
Lawrence Eichenfield files SEC Form 4 as director at VRCA (Verrica Pharmaceuticals Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lawrence Eichenfield has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | VRCA Verrica Pharmaceuticals Inc. | AGrant or award Stock Option (right to buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Jun 9, 2026 |
| Jun 5, 2025 | VRCA Verrica Pharmaceuticals Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 9, 2025 |
Questions about Lawrence Eichenfield
Answered from the filings on this page, as of the latest one.
Is Lawrence Eichenfield buying or selling?
Lawrence Eichenfield has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lawrence Eichenfield's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lawrence Eichenfield has 0.
Where does Lawrence Eichenfield file Form 4?
Lawrence Eichenfield has filed Form 4 at VRCA (Verrica Pharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.